Low-Density Lipoprotein and Oxidised Low-Density Lipoprotein: Their role in the development of atherosclerosis

Pharmacology and Therapeutics

Volumn 74, Issue 1, 1997, Pages 55-72

  Hamilton, C A ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; Low density lipoprotein; Oxidised LDL

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ADENYLATE CYCLASE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CAPTOPRIL; ENDOTHELIN; FLUINDOSTATIN; GUANYLATE CYCLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; PHOSPHATIDYLINOSITOL; PROBUCOL; RETINOL; SEROTONIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

EID: 0030789864     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(96)00202-1     Document Type: Review

References (152)

1. Aberg, G. and Ferrer, P. (1990) Effects of captopril on atherosclerosis in cynomolgus monkeys. J. Cardiovasc. Pharmacol. 15 (Suppl. 5): S65-S72.
2. Anderson, T. J., Meredith, I. T., Charbonneau, F., Yeung, A. C., Frei, B., Selwyn, A. P. and Ganz, P. (1996) Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 93: 1647-1650.
3. Andersson, T. L. G., Matz, J., Ferns, G. A. A. and Anggard, E. E. (1994) Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. Atherosclerosis 111: 39-45.
4. Andrews, H. E., Bruckdofer, K. R., Dunn, R. C. and Jacobs, M. (1987) Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature 327: 237-239.
5. Augustyn, J. M. and Ziegler, F. D. (1975) Endogenous cyclic adenosine monophosphate in tissues of rabbits fed on atherogenic diet. Science 187: 449-450.
6. Austin, M. A., Breslow, J. L., Hennekens, M. D., Buring, J. E., Willet, W. G. and Krauss, R. M. (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921.
7. Austin, M. A., King, M-C., Vranigan, K. M. and Krauss, R. M. (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82: 495-506.
8. Barakat, H. A., Carpenter, J. W., McLendon, V. D., Khazamie, P., Leggett, N., Heath, J. and Marks, R. (1990) Influence of obesity impaired glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 39: 1527-1533.
9. Baynes, J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
10. Belcher, J. D., Balla, J., Balla, G., Jacobs, D. R., Jr., Gross, M., Jacobs, M. S. and Vercellotti, G. M. (1993) Vitamin E, LDL and endothelium. Brief oral vitamin supplementation prevents oxidised LDL mediated vascular injury in vitro. Arterioscler. Thromb. 13: 1779-1789.
11. Bendich, A., D'Apoleto, P., Gabriel, E. and Machlin, L. J. (1984) Interaction of dietary vitamin C and E on guinea pig immune responses to mitogens. J. Nutr. 114: 1588-1593.
12. Berliner, J. A. and Heinecke, J. W. (1996) The role of oxidised lipoproteins in atherogenesis. Free Radic. Biol. Med. 20: 707-727.
13. Bjorkerud, B. and Bjorkerud, S. (1996) Contrary effects of lightly and strongly oxidised LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells macrophages and fibroblasts. Atherioscler. Thromb. Vasc. Biol. 16: 416-424.
14. Block, L. H., Knorr, M., Vogt, E., Locher, R., Vetter, W., Groscurth, P., Qiao, B-Y., Pometta, D., Janies, R., Regenass, M. and Pletscher, A. (1988) Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc. Natl. Acad. Sci. USA 85: 885-889.
15. Boger, R. H., Bode-Boger, S. M., Mugge, A., Kienka, S., Brandes, R., Dwenger, A. and Frolich, J. C. (1995) Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anion and restores NO production. Atherosclerosis 117: 273-284.
16. Bonanome, A., Pagnan, A., Biffanti, S., Oppotuno, A., Sorgato, F., Dorella, M., Maiorino, M. and Ursini, F. (1992) Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler. Thromb. 12: 529-533.
17. Born, G. V. R., Triggle, D. J. and Poole-Wilson, A. A. (1991a) Calcium channel antagonists: sites, control and mechanism of action relevant to the atherosclerotic process. In: Calcium Antagonism and Atherosclerosis, pp. 27-39, Dutton, J. (ed.) Publisher Science Press, London.
18. Born, G. V. R., Triggle, D. J. and Poole-Wilson, A. A. (1991b) Current clinical evaluation of the role of calcium channel antagonists in atherosclerosis. In: Calcium Antagonism and Atherosclerosis, pp. 43-58, Dutton, J. (ed.) Publisher Science Press, London.
19. Boulanger, C. M., Tanner, F. G., Bea, M-L., Hahn, A. W. A., Werner, A. and Luscher, T. F. (1992) Oxidised low density lipoproteins induce mRNA expansion and release of endothelin from human and porcine endothelium. Circ. Res. 70: 1191-1197.
20. Breugnot, C., Iliou, J. P., Privat, S., Robin, F., Vilaine, J. P. and Lenaers, A. (1992) In vitro and ex vivo inhibition of the modification of low density lipoprotein by indapamide. J. Cardiovasc. Pharmacol. 20: 340-347.
21. Bucala, R., Makita, Z., Koschinsky, T., Cerami, A. and Vlassara, H. (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA 90: 6434-6438.
22. Carew, T. E., Schwenke, D. C. and Steinberg, D. (1987) Antiatherogenic effect of probucol unrelated to its hypocholesterolaemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage rich fatty streaks and slow the progression of atherosclerosis in the Watanabe Heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA 84: 7725-7729.
23. Ceriello, A., Giugliano, D., Quatraro, A. and Lefebvre, P. J. (1991) Metabolic control may influence the increased superoxide anion production in diabetic serum. Diabet. Med. 8: 540-542.
24. Chen, L. Y., Mehta, P. and Mehta, J. L. (1996) Oxidised LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidised LDL on platelet function. Circulation 93: 1740-1746.
25. Chobanian, A. V., Haudenschild, C. C., Nickerson, C. and Drago, R. (1990) Antiatherogenic effect of captopril in the Watanabe Heritable hyperlipidemic rabbit. Hypertension 15: 327-331.
26. Chopra, M., Scott, N., McMurray, J., McLay, J., Bridges, A., Smith, W. E. and Bolch, J. J. F. (1989) Captopril: a free radical scavenger. Br. J. Clin. Pharmacol. 27: 396-399.
27. Daugherty, A., Dunn, J. L., Rateri, D. L. and Heinecke, J. W. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94: 437-444.
28. de Graaf, J., Hak-Lemmers, H. L. M., Hectors, M. C. P., Demacher, P. N. M., Hendrikss, J. C. M. and Stalenhoef, A. F. H. (1991) Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler. Thromb. 11: 298-306.
29. de Graaf, J., Hendriks, J. C. M., Demacher, A. N. M. and Stalenhoef, A. F. H. (1993) Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects: normalization after clofibrate treatment. Arterioscler. Thromb. 13: 712-719.
30. Del Rio, M., Chulia, T., Merchan-Perez, A., Remezal, M., Valor, S., Gonzalez, J., Gutierrez, J. A., Contreras, J. A., LaSuncion, M. A. and Tejerina, T. (1995) Effects of indapamide on atherosclerosis development in cholesterol-fed rabbits. J. Cardiovasc. Pharmacol. 25: 973-978.
31. Dowell, F. J. (1993) Studies in animal models of atherosclerosis. Ph.D. Thesis, University of Glasgow.
32. El-Saadami, M., Esterbauer, M., El-Sayed, M., Goher, M., Nasser, A. Y. and Jurgens, G. (1989) A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30: 627-630.
33. Esterbauer, M., Striegl, G., Puhl, H. and Rotheneder, M. (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6: 67-75.
34. Esterbauer, M., Gebichi, J., Puhl, H. and Jurgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13: 341-390.
35. Evenson, S. A., Galdal, K. S. and Nilsen, E. (1983) LDL-induced cytotoxicity and its inhibition by antioxidant treatment in cultured human endothelial cells and fibroblasts. Atherosclerosis 49: 23-39.
36. Ferns, G. A. A., Konneh, M. and Anggard, E. E. (1993) Vitamin E: the evidence for an anti-atherogeric role. Artery 20: 61-94.
37. Flavahan, N. A. and Vanhoutte, P. M. (1995) Endothelial cell signalling and endothelial dysfunction. Am. J. Hypertens. 8: 28S-41S.
38. Folcik, V. A., Nivar-Aristy, R. A., Krajewski, L. P. and Cathcart, M. K. (1995) Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96: 504-510.
39. Frei, B., Yamamoto, Y., Nidas, D. and Ames, B. N. (1988) Evaluation of an isoluminol chemiluminescence artery for detection of hydroperoxides in human blood plasma. Anal. Biochem. 175: 120-130.
40. Fruebis, J., Steinberg, D., Dresel, H. A. and Carew, T. E. (1994) A comparison of the antiatherogenic effects of probucol and of a structual analogue of probucol in low density lipoprotein receptor deficient rabbits. J. Clin. Invest. 94: 392-398.
41. Galle, J., Mulsch, A., Busse, R. and Bassenge, E. (1991) Effects of native and oxidised low density lipoproteins on formation and maturation of endothelium derived relaxing factors. Atheroscler. Thromb. 11: 193-203.
42. Galle, J., Bauersachs, J., Busse, R. and Bassenge, E. (1992) Inhibition of cyclic AMP-and cyclic GMP-mediated dilation in isolated arteries by oxidised low density lipoproteins. Arterioscler. Thromb. 12: 180-186.
43. Garg, V. C. and Hassid, A. (1989) Nitric oxide generating vasodilators and 8 bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777.
44. Gey, K. F. and Puska, P. (1989) Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann. NY Acad. Sci. 570: 268-282.
45. Gey, K. F., Moser, U. K., Jordan, P., Stahelin, H. B., Eichholzer, M. and Ludin, E. (1993) Increased risk of cardiovascular disease at suboptimal plasma concentration of essential antioxidants. An epidemiological update with special attention to carotene and vitamin C. Am. J. Clin. Nutr. 57 (Suppl): 787S-797S.
46. Godfrey, E. G., Stewart, J., Dargie, H. J., Reid, J. L., Dominiczak, M. H., Hamilton, C. A. and McMurray, J. (1994) Effects of ACE inhibitors on oxidation of human low density lipoprotein. Br. J. Clin. Pharmacol. 37: 63-66.
47. Goldstern, J. L., Ho, Y. K., Basu, S. K. and Brown, M. S. (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76: 333-377.
48. Griffin, B. A., Caslake, M. J., Yip, B., Tait, G. W., Packard, C. J. and Shepherd, J. (1990) Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 83: 59-67.
49. Griffin, B. A., Caslake, M. J., Gaw, A., Yip, B., Packard, C. J. and Shepherd, J. (1992) Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects. Eur. J. Clin. Invest. 22: 383-390.
50. Grunfeld, S., Hamilton, C. A. Mesaros, S., McClain, S. W., Dominiczak, A. F., Bohr, D. and Malinski, T. (1995) Role of Superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26: 854-857.
51. Haberland, M. E., Fong, D. and Cheng, L. (1988) Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241: 215-241.
52. Hamilton, C. A., Thorin, E., McCulloch, J., Dominiczak, M. H. and Reid, J. L. (1994) Chronic exposure of bovine aortic endothelial cells to native and oxidised LDL modifies phosphatidylinositol metabolism. Atherosclerosis 107: 55-63.
53. Harats, D., Ben-Naim, M., Debach, Y., Hollander, G., Havivi, E., Stein, O. and Stein, Y. (1990) Effect of vitamin C and E supplementation on susceptibility of plasma lioproteins to peroxidation induced by acute smoking. Atherosclerosis 85: 47-54.
54. Hazell, L. J. and Stocker, R. (1993) Oxidation of low density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high uptake form for macrophages. Biochem. J. 290: 165-172.
55. Hazell, L. J., Arnold, L., Flowers, D., Waez, G., Malle, E. and Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97: 1535-1544.
56. He, Y., Kwan, W. C. P. and Steinbrecher, V. P. (1996) Effects of oxidised low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages. Atherosclerosis 119: 107-118.
57. Heinecke, J. W., Baker, L., Rosen, H. and Chait, A. (1986) Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77: 757-761.
58. Henriksen, T., Mahoney, E. and Steinberg, D. (1981) Enhanced macrophage degradation of LDL previously incubated with cultured endothelial cells: recognition by receptor for acetylated LDL. Proc. Natl. Acad. Sci. USA 78: 6499-6503.
59. Hense, H. W., Stender, M., Bors, W. and Keil, V. (1993) Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis 103: 21-28.
60. Higuchi, Y. (1982) Lipid peroxides and α tocopherol in rat streptozotocin induced diabetes. Acta Med. Okayama 3: 165-175.
61. Hirata, K., Akita, H. and Yokoyama, M. (1991) Oxidised low density lipoprotein inhibits bradykinin-induced phosphoinositide hydrolysis in cultured bovine aortic endothelial cells. FEBS Lett. 287: 181-184.
62. Hirata, K., Miki, N., Kuroda, Y., Sakoda, T., Kawashima, S. and Yokoyama, M. (1995) Low concentration of oxidised low density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ. Res. 76: 958-962.
63. Huber, L. A., Scheffler, E., Poll, T., Ziegler, R. and Dresel, H. A. (1990) 17β Oestradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radic. Res. Commun. 8: 167-173.
64. Irita, K., Fujita, I., Takeshige, K., Minakami, S. and Yoshitake, K. (1986) Calcium channel antagonist induced inhibitory superoxide production in human neutrophils. Mechanisms independent of antagonising calcium influx. Biochem. Pharmacol. 35: 3465-3471.
65. Jacobs, M., Plane, F. and Bruckdorfer, K. R. (1990) Native and oxidised low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br. J. Pharmacol. 100: 21-26.
66. Jialal, I. and Grundy, S. M. (1991) Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J. Clin. Invest. 87: 597-601.
67. Jialal, I. and Grundy, S. M. (1993) Effect of combined supplementation with α tocopherol ascorbate and beta carotene on low density lipoprotein oxidation. Circulation 88: 2780-2786.
68. Jialal, I., Vega, G. L. and Grundy, M. (1990) Physiological levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 82: 188-191.
69. Kirchenbaum, M. A., Roh, D. D. and Kamanna, V. S. (1991) Effect of nifedipine on renal microvascular cholesterol accumulation and prostacyclin biosynthesis in cholesterol fed rabbit. Atherosclerosis 91: 241-246.
70. Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Naramuga, S. and Kawai, C. (1988) Prevention of atherosclerotic progression in Watanabe rabbits by probucol. Am. J. Cardiol. 62: 13B-19B.
71. Kleinveld, M. A., Naber, A. H. J., Stalenhoef, A. F. H. and Demacher, P. N. M. (1993) Oxidation resistance, oxidation rate, and extent of oxidation of human low density lipoprotein depend on the ratio of oleic acid content to linoleic content: studies in vitamin E deficient subjects. Free Radic. Biol. Med. 15: 273-280.
72. Knight, J. A., Pieper, R. K. and McClellan, L. (1988) Specificity of the thiobarbituric acid reaction: its uses in studies of lipid peroxidation. Clin. Chem. 34: 2435-2438.
73. Kok, F. J., de Bruijn, A. M., Vetmeeren, R., Hofman, A., Van Laar, A., de Bruin, M., Hermus, R. J. J. and Valkenburg, H. A. (1987) Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9 year follow-up study in the Netherlands. Am. J. Clin. Nutr. 45: 462-468.
74. Krauss, R. M. and Burke, D. J. (1981) Identification of multiple subclasses of plasma lipoproteins in normal humans. J. Lipid Res. 23: 97-104.
75. Kugiyama, K., Kerns, S. A., Morrissett, J. D., Roberts, R. and Henry, P. D, (1990) Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature 344: 160-162.
76. Kuhn, H., Belbner, J., Zaiss, T., Fahrenklemper, T. and Wohfeil, S. (1994) Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179: 1903-1911.
77. Kumar, K. W. and Das, U. M. (1993) Are free radicals involved in the patho-biology of human essential hypertension. Free Radic. Res. Commun. 19: 59-66.
78. Lamon-Fava, S., Jimenez, D., Christian, J. C., Fabsitz, R. R., Reed, T., Carmelli, D., Castelli, W. P., Ordovas, J. M., Wilson, P. W. and Schaefer, E. J. (1991) The NHLBI Twin Study: heritability of apolipoprotein A-1, B and low density lipoprotein subclasses and concordance for lipoprotein. Atherosclerosis 91: 97-106.
79. Lerman, A., Edwards, B. S., Hallett, J. W., Heliblein, D. M., Sandberg, S. M. and Burnett, J. C. (1991) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Eng. J. Med. 325: 997-1001.
80. Liu, S., Beckman, J. S. and Ku, D. D. (1994) Peroxynitrite a product of superoxide and nitric oxide produces coronary vasorelaxation in dogs. J. Pharmacol. Exp. Ther. 268: 1114-1121.
81. Livrea, M. A., Tesoriere, L., Bongiorno, A., Pintaudi, A. M., Ciaccio, M. and Riccio, A. (1995) Contribution of vitamin A to the oxidation resistance of human low density lipoproteins. Free Radic. Biol. Med. 18: 401-409.
82. Lui, K., Cuddy, T. E. and Pierce, G. N. (1992) Oxidative status of lipoproteins in coronary disease patients. Am. Heart J. 123: 285-290.
83. Maggi, E., Marchesi, E., Ravetta, V., Falashi, F., Finardi, G. and Bellomo, G. (1993) Low density lipoprotein oxidation in essential hypertension. J. Hypertens. 11: 1103-1111.
84. Maggi, E., Bellazzi, R., Falaschi, F., Frattoni, A., Perani, G., Funardi, G., Gazo, A., Nai, M., Romanini, D. and Bellomo, G. (1994a) Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis. Kidney Int. 45: 876-883.
85. Maggi, E., Chiesa, R., Melissano, G., Castellano, R., Astore, D., Grossi, A., Funardi, G. and Bellomo, G. (1994b) LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler. Thromb. 14: 1892-1899.
86. Maggi, E., Marchesi, E., Ravetta, V., Martignoni, A., Finardi, G. and Bellomo, G. (1995) Presence of auto-antibodies against oxidatively modified low density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J. Hypertens. 13: 129-138.
87. Mangin, E.L., Kugiyama, K., Nguy, J.H., Kerns, S.A. and Henry, P.D. (1993) Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium dependent relaxation of rabbit aorta. Circ. Res. 72: 161-166.
88. Mantha, S. V., Prasad, M., Kalra, J. and Prasad, K. (1993) Antioxidant enzymes in hypercholesterotemia and effects of vitamin E in rabbits. Atherosclerosis 101: 135-144.
89. McPherson, K. L., Hamilton, C. A., Dominiczak, A. F. and McIntyre, M. (1995) Effects of oxidised LDL on basal and stimulated nitric oxide release in rat aorta. Br. J. Pharmacol. 116: 317P.
90. Mironova, M., Virella, G. and Lopes-Virella, M. F. (1996) Isolation and characterisation of human antioxidized LDL autoantibodies. Arterioscler. Thromb. Vasc. Biol. 16: 222-229.
91. Miyauchi, T., Sugishita, Y., Matsuda, M., Sakai, H., Suzuki, N., Masaki, T. and Goto, K. (1992) Increased plasma concentration of endothelin-1 in cholesterol fed rats. Atherosclerosis 93: 257-259.
92. Mohan, P. F. and Jacobson, M. S. (1995) Effect of lipoproteins on macrophage superoxide generation. Cell Biochem. Funct. 13: 135-140.
93. Molgaard, J., Carlsson, M., Nilsson, J. and Olssan, A. G. (1990) Decreased mitogenic activity in hypercholesterolaemic plasma. J. Int. Med. 227: 339-345.
94. Mugge, A., Brandes, R. P., Boger, R. H., Dwenger, A., Bode-Boger, S., Kienke, S., Frolich, J. C. and Lichtlen, P. R. (1994) Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 24: 994-998.
95. Musliner, T. A. and Krauss, R. M. (1988) Lipoprotein subspecies and risk of coronary disease. Clin. Chem. 34: B78-B83.
96. Myers, D. E., Fidge, N. H., Stanton, H. and Larkins, R. G. (1992) The effects of low density lipoprotein and high density lipoprotein on phosphoinositide hydrolysis in bovine aortic endothelial cells. Atherosclerosis 92: 9-14.
97. Ohara, Y., Peterson, T. E., Sayegh, H. S., Subramanian, R. R., Wilcox, J. N., David, J. N. and Harrison, D. G. (1995) Dietary correction of hypercholesterolemia in the rabbit normalises endothelial superoxide anion production. Circulation 92: 898-903.
98. Ohkawa, H., Ohishi, N. and Yagi, K. (1978) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358.
99. Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurter, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E. and Steinberg, D. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86: 1372-1376.
100. Pohl, V., Heydari, N. and Galle, J. (1995) Effects of LDL on intracellular free calcium and nitric oxide dependent cGMP formation in porcine endothelial cells. Atherosclerosis 117: 169-178.
101. Pritchard, K. A., Schwarz, S. M., Medow, M. S. and Stemerman, M. B. (1991) Effect of low density lipoprotein on endothelial cell membrane fluidity and non-nuclear cell attachment. Am. J. Physiol. 260: C43-C49.
102. Pritchard, K. A., Groszek, L., Smalley, D. M., Sessa, W. C., Wu, M., Villalon, P., Wolin, M. S. and Stemerman, M. B. (1995) Native low density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anions. Cir. Res. 77: 510-518.
103. Raal, F. J., Areias, A. J., Pilcher, G., Joffe, B. I. and Seftel, H. C. (1994) Lack of effect of high dose vitamin E on xanthoma regression in homozygous familial hypercholesterolaemia. Atherosclerosis 107: 213-219.
104. Rapola, J. M., Virtamo, J., Haukka, J. K., Heinonen, O. P., Albanes, D., Taylor, P. R. and Hultunen, J. K. (1996) Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomised, double blind, controlled trial. JAMA 275: 693-698.
105. Reaven, P. D., Parthasarathy, S., Beltz, W. F. and Witztum, J. L. (1992) Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein agonist in vitro oxidation in humans. Arterioscler. Thromb. 12: 318-324.
106. Reaven, P. D., Khouw, A., Beltz, W. F., Parthasarathy, S. and Witztum, J. L. (1993) Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by β-carotene. Arterioscler. Thromb. 13: 590-600.
107. Regnström, J., Nilsson, J., Tornvall, P, Landou, C. and Hamsten, A. (1992) Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339: 1183-1186.
108. Resink, T. J., Trachuk, V. A., Bernhardt, J. and Buhler, F. R. (1992) Oxidised low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler. Thromb. 12: 278-285.
109. Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A. and Willett, W. C. (1993) Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328: 1450-1456.
110. Sachinidis, A., Locher, R., Mengden, T. and Vetter, W. (1990a) Low density lipoprotein elevates intracellular calcium and pH in vascular smooth muscle cells and fibroblasts without mediation of LDL receptor. Biochem. Biophys. Res. Commun. 167: 353-359.
111. Sachinidis, A., Mengden, T., Locher, R., Brunner, C. and Vetter, W. (1990b) Novel cellular activities for low density lipoproteins in vascular smooth muscle cells. Hypertension 15: 704-711.
112. Salonen, J. T., Salonon, R., Penttila, I., Herranen, J., Jauhiainen, M., Kantda, M., Lappetelainen, R., Maenpaa, P. H., Alfthan, G. and Puska, P. (1985) Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am. J. Cardiol. 56: 226-231.
113. Schectman, G., Byrd, J. C. and Gruchow, H. W. (1989) The influence of smoking on vitamin C status in adults. Am. J. Public Health 79: 158-162.
114. Schmidt, K., Graier, W. F., Kostner, G. M., Mayer, B., Böhme, E. and Kukovetz, W. R. (1991) Stimulation of soluble guanylate cyclase by endothelium derived relaxing factor is antagonised by oxidised low density lipoprotein. J. Cardiovasc. Pharmacol. 17 (Suppl.3): S83-S88.
115. Schmidt, K., Klatt, P. and Mayer, B. (1993) Hypercholesterolemia is associated with a reduced response of smooth muscle guanylyl cyclase to nitrovasodilators. Arterioscler. Thromb. 13: 1159-1163.
116. Schumacher, M. L., Eber, B., Tatzber, F., Kaufmann, P., Esterbauer, H. and Klein, W. (1992) LDL oxidation and coronary atherosclerosis. Lancet 340: 123.
117. Scott-Burden, T., Resink, T. J., Hahn, A. W. A., Baur, V., Box, R. J. and Buhler, F. R. (1989) Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoproteins. J. Biol. Chem. 264: 12582-12589.
118. Selby, J. V., Newman, B., Quiroga, J., Christian, J. C., Austin, M. A. and Fabsitz, R. R. (1991) Concordance for dyslipidemic hypertension in male twins. JAMA 265: 2079-2084.
119. Selby, J. V., Austin, M. A., Newman, B., Zhang, D., Quesenberry, C. P., Mayer, E. J. and Krauss, R. M. (1993) LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88: 381-387.
120. Sharma, R. C., Crawford, D. W., Kramsch, D. M., Sevanian, A. and Jiao, Q. (1992) Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries: role of oxygen free radicals. Arterioscler. Thromb. 12: 403-415.
121. Shinitzky, M. (1984) Membrane fluidity and cellular functions. In: Physiology of Membrane Fluidity, Vol. 1, pp. 1-51, Shinitzky, M. (ed.) CRC Press Inc., Boca Raton.
122. Simon, B. C., Cunningham, L. D. and Cohen, R. A. (1990) Oxidised low density lipoprotein causes contraction and inhibits endothelium dependent relaxation in the pig coronary artery. J. Clin. Invest. 86: 75-79.
123. Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B. and Willett, W. C. (1993) Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328: 1444-1449.
124. Stephens, N. G., Parsons, A., Schofield, P. M., Kelly, F., Cheeseman, K. and Mitchinson, M. J. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781-785.
125. Stepp, D. W. and Tulenko, T. N. (1991) Alterations in basal and serotonin-stimulated calcium permeability and vasoconstriction in atherosclerotic aorta. Arterioscler. Thromb. 14: 1854-1859.
126. Stiko, A., Regnstrom, J., Shah, P. K., Cercek, B. and Nilsson, J. (1996) Active oxygen species and lysophosphatidycholine are involved in oxidised low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler. Thromb. Vasc. Biol. 16: 194-200.
127. Stiko-Rahm, A., Hultgardh-Nilsson, A., Regnstrom, J., Hamsten, A. and Nilsson, J. (1992) Native and oxidised LDL enhances production of PDGF AA and surface expression of PDGF receptors in cultured human arterial smooth muscle cells. Arterioscler. Thromb. 12: 1099-1109.
128. Strickberger, S. A., Russek, L. N. and Phair, R. D. (1988) Evidence for increased aortic plasma membrane calcium transport caused by experimental atherosclerosis in rabbits. Circ. Res. 62: 75-80.
129. Superko, H. R. and Krauss, R. M. (1992) Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis 95: 69-76.
130. Superko, H. R. and Wood, P. D. (1989) Effect of alpha and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses and postprandial lipemia. Am. J. Med. 86: 26-31.
131. Tasaki, H., Nakashima, Y., Segawei, J., Kouzuma, R., Kuroiwa, A., Sparks, D. L. and Tulenko, T. N. (1994) Promotion of aortic smooth muscle cell proliferation by hypercholesterolemic LDL and its suppression by heparin or sulphated glycosaminoglycans. Cell. Physiol. Biochem. 4: 57-71.
132. Thands, S. M., Jessup, W., Gebicki, J. M. and Dean, R. T. (1989) A continuous-flow automated assay for iodometric estimation of hydroperoxides. Anal. Biochem. 176: 353-359.
133. Thorin, E., Hamilton, C. A., Dominiczak, M. H. and Reid, J. L. (1994) Chronic exposure of cultured bovine endothelial cells to oxidised low density lipoprotein abolishes prostacyclin release. Arterioscler. Thromb. 14: 453-459.
134. i of bovine aortic endothelial cells: influence of vitamin E. Atherosclerosis 114: 185-195.
135. Triau, J. E., Meydani, S. N. and Schaefer, E. J. (1988) Oxidised low density lipoprotein stimulates prostacyclin production by adult human vascular endothelial cells. Atherosclerosis 8: 810-818.
136. Tsai, M. Y., Yuan, J. and Hunninghake, D. B. (1992) Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies. Atherosclerosis 95: 35-42.
137. Tse, W. Y., Maxwell, S. R. J., Thomason, H., Biann, A., Thorpe, G. H. G., Waite, M. and Holder, R. (1994) Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J. Hum. Hypertens. 8: 843-849.
138. Vericel, E., Narce, M., Ulmann, L., Poisson, H. J-P. and Lagarde, M. (1994) Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol. Cell. Biochem. 132: 25-29.
139. Virella, G., Virella, I., Leman, R. B., Pryor, M. B. and Lopes-Virella, M. F. (1993) Anti-oxidised low density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int. J. Clin. Lab. Res. 23: 95-101.
140. Weisser, B., Locher, R., Mengden, T. and Vetter, W. (1992) Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells. Arterioscler. Thromb. 12: 231-236.
141. Weisser, B., Locher, R., Lehmann, E., de Graaf, J. and Vetter, W. (1993) Proliferative effects of low density lipoprotein subfraction on vascular smooth muscle cells: potentiation by insulin. J. Hypertens. 11 (Suppl. 5): S126-S127.
142. Williams, P. T., Krauss, R. M., Vranizan, K. M. and Wood, P. D. S. (1990) Changes in lipoprotein subfraction during diet-induced and exercise induced weight loss in moderately overweight men. Circulation 81: 1293-1304.
143. Witztum, J. L., Young, S. G., Elam, R. L., Carew, T. E. and Fisher, M. (1985) Cholestyramine-induced changes in low density lipoprotein composition and metabolism 1. Studies in the guinea pig. J. Lipid Res. 26: 92-103.
144. Yanagisawa, M. and Masaki, T. (1989) Endothelin, a novel endothelium-derived peptide: pharmacological activities, regulation and possible roles in cardiovascular control. Biochem. Pharmacol. 38: 1877-1883.
145. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
146. Yang, X., Cai, B., Sciacca, R. R. and Cannon, P. J. (1994) Inhibition of inducible nitric oxide synthase in macrophages by oxidised low-density lipoproteins. Circ. Res. 74: 318-328.
147. Ylä-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L. and Steinberg, D. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
148. Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Glass, C. K., Sigal, E., Witztum, J. L. and Steinberg, D. (1990) Colocalisation of 15-lipoxygenase mRNA and protein with epitopes of oxidised low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 87: 6959-6963.
149. Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Sigal, E., Sarkioja, T., Witztum, J. L. and Steinberg, D. (1991) Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid protein adducts. J. Clin. Invest. 87: 1146-1152.
150. Young, S. G., Witztum, J. L., Carew, T. E., Krauss, R. M. and Lindgren, F. (1989) Colestipol-induced changes in LDL composition and metabolism II. Studies in humans. J. Lipid Res. 30: 225-238.
151. Yuan, J., Tsai, M. Y., Hegland, J. and Hunninghake, D. B. (1991) Effects of fluvastatin (XU 62-320) an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans. Atherosclerosis 87: 147-157.
152. Zhao, B., Dierichs, R., Liu, J. F., Zhu, Z. M., Berkes, P. and Frye, S. (1993) Influence of low density lipoproteins on cytsolic free calcium concentration and dense tubular systems in human platelets. Thromb. Res. 72: 35-37.